CSIMarket
 
Outset Medical Inc   (NASDAQ: OM)
 
Price: $3.6700 $0.03 0.824%
Day's High: $3.841599941253662 Week Perf: -10.27 %
Day's Low: $ 3.65 30 Day Perf: -29.69 %
Volume (M): 69,950 52 Wk High: $ 16.16
Volume (M$): $ 0 52 Wk Avg: $6.14
Open: $3.66 52 Wk Low: $3.00



 Market Capitalization (Millions $) 67
 Shares Outstanding (Millions) 18
 Employees 310
 Revenues (TTM) (Millions $) 117
 Net Income (TTM) (Millions $) -75
 Cash Flow (TTM) (Millions $) -45
 Capital Exp. (TTM) (Millions $) 1

Business Description


Outset Medical Inc. is a pioneering medical technology company that offers innovative solutions for the delivery of hemodialysis treatment. The company was founded in 2003 by Leslie Trigg, who was inspired to create a better experience for hemodialysis patients after witnessing her fatheres struggles with the treatment.

Outset Medicales flagship product is the Tablo Hemodialysis System, which streamlines the hemodialysis process by integrating multiple functions that are typically performed by separate machines. Tablo consists of a small, mobile machine that can be used in hospitals, clinics, and patientse homes. The system can automatically monitor and adjust dialysis parameters, and it can also generate real-time diagnostic information that can help providers make more informed decisions about patient care.

Tablo is designed to be easy to use, and it features a touch-screen interface that guides patients and providers through the treatment process. In addition, Tablo is designed to minimize the use of consumables, reduce water usage, and lower treatment costs.

Outset Medical has received significant recognition for its innovative technology. In 2021, the company was named one of Fast Companyes Most Innovative Companies in the Biotech category. In addition, the Tablo Hemodialysis System has received FDA clearance and is currently used in clinics across the United States.

The company has also attracted significant investment, raising $277 million in a Series D funding round in 2020. Outset Medical is headquartered in San Jose, California, and has additional offices in Minnesota and Georgia. The company has a team of over 400 employees and is continuing to grow as they expand their offerings and bring better medical solutions to the industry.


   Company Address: 3052 Orchard Dr. San Jose 95134 CA
   Company Phone Number: 231-8200   Stock Exchange / Ticker: NASDAQ OM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -3.02%    
ICUI   -5.42%    
KRMD        2.8% 
NEPH        4.07% 
DVA   -0.37%    
• View Complete Report
   



Product Service News

Transforming Home Healthcare Outset Medical and Northwest Kidney Centers Unite for Innovative Dialysis Solutions

Published Thu, Sep 4 2025 4:29 AM UTC

In a strategic partnership, Northwest Kidney Centers and Outset Medical have announced a collaboration aimed at enhancing patient care through innovative home dialysis solutions. This initiative will provide patients and caregivers with greater access to the Tablo Hemodialysis System, a cutting-edge device designed to make home hemodialysis more accessible and manageable.The...

Shares

Outset Medical Implements Reverse Stock Split Amid Legal Challenges: What It Means for Shareholders

Published Tue, Mar 18 2025 12:30 PM UTC

Outset Medical s Strategic Move: The One-for-Fifteen Reverse Stock Split ExplainedIn a significant development for investors and stakeholders alike, Outset Medical, Inc. (Nasdaq: OM), a cutting-edge medical technology firm known for its efforts to streamline dialysis processes, announced a one-for-fifteen reverse stock split, effective March 20, 2025. The decision, though ro...

Announcement

Investors on Alert Legal Challenges Emerge for Outset Medical, Inc. Amid Class Action Lawsuits

Published Mon, Sep 16 2024 5:12 PM UTC

In a significant turn of events for investors in Outset Medical, Inc. (NASDAQ: OM), recent legal actions have raised concerns about potential violations of federal securities laws. Prominent law firms, including Levi & Korsinsky, LLP and Bragar Eagel & Squire, P.C. have signaled their intent to investigate the company on behalf of stockholders, prompting a closer look at Out...

Announcement

Class Action Alert Shareholders Urged to Seek Legal Counsel in Outset Medical, Inc. (NASDAQ OM) Lawsuit,

Published Mon, Sep 9 2024 9:30 PM UTC

Shareholder Class Action Lawsuit Filed Against Outset Medical, Inc. (NASDAQ: OM): Investors Advised to Seek Legal Counsel Investors holding shares in Outset Medical, Inc. (NASDAQ: OM) have recently been alerted to a class action lawsuit filed against the company. The lawsuit encompasses allegations that could have significant repercussions for the stakeholders involved. In l...

Announcement

Outset Medical Faces Investigation Amid Strong Revenue Growth

Published Sun, Aug 11 2024 1:00 AM UTC

In a developing story that concerns shareholders of Outset Medical, Inc. (NASDAQ: OM), the law firm Bragar Eagel & Squire, P.C. has initiated an investigation into potential violations of federal securities laws by the medical technology company. The investigation comes in light of significant revenue growth reported by Outset Medical, which could be contrasted with concerns...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.58
Price to Sales (Expected) -
Price to Book 0.6
PEG (TTM) -

Financial Strength Current
Quick Ratio 4.17
Working Capital Ratio 6.29
Leverage Ratio (MRQ) 1.23
Total Debt to Equity 0.87
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -4.35 $
Revenues (TTM) 6.36 $
Cash Flow (TTM) -
Cash 8.53 $
Book Value 6.08 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 376,719
Net Income per Employee (TTM) -241,445
Receivable Turnover Ratio (TTM) 3.84
Inventory Turnover Ratio (TTM) 1.39
Asset Turnover Ratio (TTM) 0.43

Profitability Ratios Current
Gross Margin (MRQ) 44.64 %
Operating Margin (MRQ) -62.44 %
Net Margin (MRQ) -70.04 %
Net Cash Flow Margin (MRQ) -16.4 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Outset Medical Inc's Segments
Consoles Product    19.83 % of total Revenue
Consumables Product    48.64 % of total Revenue
Product Revenue    68.46 % of total Revenue
Service and Other Revenue    34.37 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.